A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial). (Q33396382)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial). |
scientific article |
Statements
1 reference
A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial). (English)
1 reference
Joyce M van Dodewaard-de Jong
1 reference
John M H de Klerk
1 reference
Haiko J Bloemendal
1 reference
Bart P J van Bezooijen
1 reference
Marie J de Haas
1 reference
Richard H Wilson
1 reference
Joe M O'Sullivan
1 reference
27 July 2011
1 reference
38
1 reference
11
1 reference
1990-1998
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference